COVID-19合并急性低氧性呼吸衰竭患者的无创通气
该回顾性队列纳入两家大学附属医院普通病房中确诊COVID-19并接受NIV的AHRF患者61例,NIV失败定义为住院期间插管或死亡。NIV成功44/61例(72.1%),失败17例中插管17例、死亡15例,总死亡率24.6%。失败组年龄更大,NIV前呼吸频率、PaCO2、D-二聚体更高,NIV第1天分钟通气量和通气比更高。研究期间无医护人员感染SARS-CoV-2。作者认为NIV在ICU外对这类患者可行,可作为管理选项。
要点
- 普通病房COVID-19合并AHRF患者接受NIV,61例中44例(72.1%)成功,17例失败者中15例死亡,总死亡率24.6%。
- NIV失败组较成功组年龄更大,NIV前呼吸频率、PaCO2、D-二聚体更高。
- NIV失败组第1天分钟通气量和通气比更高。
- 研究期间无医护人员感染SARS-CoV-2。
- 作者结论为NIV在ICU外对COVID-19合并AHRF可行,可考虑作为管理选项。
适用人群与场景
- 两家大学附属医院普通病房中确诊COVID-19并接受NIV的急性低氧性呼吸衰竭(AHRF)患者。
诊断标准与关键阈值
- NIV失败定义为住院期间插管或死亡。
- 原文未提及NIV启动或停止的具体阈值。
处置流程与药物剂量
- 原文未提及NIV的具体模式、参数设置、药物剂量或疗程。
红旗征与不能漏的情况
- NIV失败组年龄更大,NIV前呼吸频率、PaCO2、D-二聚体更高,第1天分钟通气量和通气比更高;原文未提及具体阈值或处理。
研究设计与关键结果
- 回顾性队列研究,纳入两家大学附属医院普通病房61例确诊COVID-19合并AHRF接受NIV的患者。
- NIV成功44/61例(72.1%);失败17例,其中插管17例、死亡15例;总死亡率24.6%。
- NIV失败组较成功组年龄更大,NIV前呼吸频率、PaCO2、D-二聚体更高,第1天分钟通气量和通气比更高。
- 研究期间无医护人员感染SARS-CoV-2。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未述局限性。
对床旁实践的改变
- 在普通病房对COVID-19合并AHRF患者使用NIV时,需关注年龄、NIV前呼吸频率、PaCO2、D-二聚体及第1天分钟通气量和通气比,这些因素在NIV失败组更高。
- 原文未提及适用与不适用人群的具体推荐或常见陷阱。
指南或共识出处
- 来源:Am J Emerg Med;标题:Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19.
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute hypoxemic respiratory failure (AHRF). We aimed to assess the outcomes of NIV application in COVID-19 patients with AHRF.
MATERIALS & METHODS: In this retrospective cohort study, patients with confirmed diagnosis of COVID-19 and AHRF receiving NIV in general wards were recruited from two university-affiliated hospitals. Demographic, clinical, and laboratory data were recorded at admission. The failure of NIV was defined as intubation or death during the hospital stay.
RESULTS: Between April 8 and June 10, 2020, 61 patients were enrolled into the final cohort. NIV was successful in 44 out of 61 patients (72.1%), 17 patients who failed NIV therapy were intubated, and among them 15 died. Overall mortality rate was 24.6%. Patients who failed NIV were older, and had higher respiratory rate, PaCO2, D-dimer levels before NIV and higher minute ventilation and ventilatory ratio on the 1-st day of NIV. No healthcare workers were infected with SARS-CoV-2 during the study period.
CONCLUSIONS: NIV is feasible in patients with COVID-19 and AHRF outside the intensive care unit, and it can be considered as a valuable option for the management of AHRF in these patients.
参考来源
- Avdeev SN, Yaroshetskiy AI, Tsareva NA, et al. Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19. Am J Emerg Med. 2020. PMID: 33067061. doi:10.1016/j.ajem.2020.09.075
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。